Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Significant Growth in Short Interest

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totaling 161,400 shares, a growth of 29.6% from the December 15th total of 124,509 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

Ascentage Pharma Group International Stock Performance

Shares of OTCMKTS ASPHF opened at $8.48 on Tuesday. The business has a 50-day moving average of $8.60 and a 200-day moving average of $8.48. Ascentage Pharma Group International has a fifty-two week low of $7.50 and a fifty-two week high of $10.65.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.

Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.